Matthew O'Brien's Stock Ratings

Piper Sandler Analyst

Matthew O'Brien is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

10.1%

Smart Score

63.9%

Overall Average Return Percentile

58th

Number of Ratings

36
Buy NowGet Alert
07/01/2024ZBHBuy Now
Zimmer Biomet Holdings
$92.4324.42%$140 → $115DowngradeOverweight → NeutralGet Alert
05/08/2024ATECBuy Now
Alphatec Holdings
$19.71-13.75%$19 → $17MaintainsOverweightGet Alert
01/05/2023ZBHBuy Now
Zimmer Biomet Holdings
$92.4340.65%$120 → $130MaintainsNeutralGet Alert
08/02/2022ZBHBuy Now
Zimmer Biomet Holdings
$92.4329.83%$130 → $120MaintainsNeutralGet Alert
05/03/2022ZBHBuy Now
Zimmer Biomet Holdings
$92.4340.65%$110 → $130MaintainsNeutralGet Alert
03/14/2022SPNEBuy Now
SeaSpine Holdings
$28 → $21MaintainsOverweightGet Alert
03/02/2022ATECBuy Now
Alphatec Holdings
$19.71-13.75%$22 → $17MaintainsOverweightGet Alert
02/24/2022PODDBuy Now
Insulet
$291.51-21.1%$295 → $230MaintainsNeutralGet Alert
02/07/2022ZBHBuy Now
Zimmer Biomet Holdings
$92.4319.01%$135 → $110MaintainsNeutralGet Alert
01/26/2021KRMDBuy Now
KORU Medical Systems
$5.81-22.55%$9 → $4.5DowngradeOverweight → NeutralGet Alert
01/08/2021ZBHBuy Now
Zimmer Biomet Holdings
$92.43100.15%$160 → $185MaintainsOverweightGet Alert
11/05/2020ZBHBuy Now
Zimmer Biomet Holdings
$92.4373.1% → $160MaintainsOverweightGet Alert
11/02/2020AZYOBuy Now
Aziyo Biologics
→ $20Initiates → OverweightGet Alert
10/29/2020IARTBuy Now
Integra Lifesciences
$13.47248.92%$53 → $47MaintainsNeutralGet Alert
09/21/2020ZBHBuy Now
Zimmer Biomet Holdings
$92.4373.1% → $160MaintainsOverweightGet Alert
08/04/2020ZBHBuy Now
Zimmer Biomet Holdings
$92.4373.1% → $160MaintainsOverweightGet Alert
05/11/2020ZBHBuy Now
Zimmer Biomet Holdings
$92.4373.1%$175 → $160MaintainsOverweightGet Alert
01/07/2020IARTBuy Now
Integra Lifesciences
$13.47330.59%$59 → $58DowngradeOverweight → NeutralGet Alert
01/07/2020ZBHBuy Now
Zimmer Biomet Holdings
$92.4383.92%$140 → $170UpgradeNeutral → OverweightGet Alert
08/05/2019ATECBuy Now
Alphatec Holdings
$19.71-64.49% → $7Initiates → OverweightGet Alert
07/27/2018BAXBuy Now
Baxter Intl
$19.53324.99%$77 → $83MaintainsOverweightGet Alert
05/24/2018ALGNBuy Now
Align Tech
$162.7399.72%$300 → $325MaintainsOverweightGet Alert
03/12/2018MOTSBuy Now
Motus GI Hldgs
$0.006999900% → $7Initiates → OverweightGet Alert
11/02/2017ZBHBuy Now
Zimmer Biomet Holdings
$92.43DowngradeOverweight → NeutralGet Alert
05/22/2017DXCMBuy Now
DexCom
$65.7318.67% → $78Reinstates → OverweightGet Alert
04/06/2017ABMDBuy Now
Abiomed
UpgradeNeutral → OverweightGet Alert
03/03/2017MDXGBuy Now
MiMedx Group
$7.1240.45% → $10Initiates → OverweightGet Alert
07/02/2015SPNEBuy Now
SeaSpine Holdings Corporation - Common Stock
→ $24Initiates → OverweightGet Alert
03/10/2015IARTBuy Now
Integra Lifesciences
$13.47397.4% → $67Initiates → OverweightGet Alert
08/15/2013IARTBuy Now
Integra Lifesciences
$13.47271.2%$41 → $50UpgradeNeutral → OverweightGet Alert
04/11/2013IARTBuy Now
Integra Lifesciences
$13.47204.38%$46 → $41MaintainsNeutralGet Alert
04/09/2013ABMDBuy Now
Abiomed
→ $18DowngradeOverweight → NeutralGet Alert
02/22/2013IARTBuy Now
Integra Lifesciences
$13.47241.5%$43 → $46MaintainsNeutralGet Alert
07/30/2012IARTBuy Now
Integra Lifesciences
$13.47204.38%$40 → $41MaintainsNeutralGet Alert
05/17/2012ABMDBuy Now
Abiomed
$25 → $27MaintainsOverweightGet Alert
02/24/2012IARTBuy Now
Integra LifeSciences Holdings
$13.47152.41%$35 → $34MaintainsNeutralGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free